Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Dose and treatment duration: Higher doses and longer treatment periods might increase the risk of muscle loss
Most patients experience improvement in fatigue within 48 weeks as their bodies adapt to the medication and gastrointestinal side effects diminish
Any FDA approval date
Melasma treatment with combined chemical peels and a novel topical agent containing an antiestrogen and a vascular endothelial growth factor inhibitor
The GLORY-1 trial used 4 mg and 6 mg over 48 weeks, while GLORY-2 tested 9 mg over 60 weeks
US$ 29.57
US$ 20.81
US$ 25.44
US$ 28.78
US$ 29.97
